{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:57:58Z","timestamp":1793332678103,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T00:00:00Z","timestamp":1500854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.cell.2017.07.025","type":"journal-article","created":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T17:31:21Z","timestamp":1503682281000},"page":"927-938.e20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":431,"title":["Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient"],"prefix":"10.1016","volume":"170","author":[{"given":"Alejandro","family":"Jim\u00e9nez-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danish","family":"Memon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Pourpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harini","family":"Veeraraghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hebert Alberto","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Zivanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Konner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Ricca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitriy","family":"Zamarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Walther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Aghajanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jedd D.","family":"Wolchok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evis","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Merghoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin L.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2017.07.025_bib1","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-17-0270","article-title":"Transcriptional mechanisms of resistance to anti-PD-1 therapy","volume":"23","author":"Ascierto","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2017.07.025_bib2","doi-asserted-by":"crossref","first-page":"10094","DOI":"10.1073\/pnas.88.22.10094","article-title":"Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region","volume":"88","author":"Bahram","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2017.07.025_bib3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08460","article-title":"Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1","volume":"462","author":"Barbie","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.cell.2017.07.025_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/path.4230","article-title":"Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling","volume":"231","author":"Bashashati","year":"2013","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.cell.2017.07.025_bib5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.285.5428.727","article-title":"Activation of NK cells and T\u00a0cells by NKG2D, a receptor for stress-inducible MICA","volume":"285","author":"Bauer","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.cell.2017.07.025_bib6","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.cell.2016.11.022","article-title":"Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade","volume":"167","author":"Benci","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cell.2017.07.025_bib7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.tcb.2004.05.003","article-title":"GAP control: regulating the regulators of small GTPases","volume":"14","author":"Bernards","year":"2004","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.cell.2017.07.025_bib8","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nm.3841","article-title":"Studying clonal dynamics in response to cancer therapy using high-complexity barcoding","volume":"21","author":"Bhang","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2017.07.025_bib9","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2017.07.025_bib10","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/nm.3327","article-title":"Roadblocks to translational advances on metastasis research","volume":"19","author":"Brabletz","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2017.07.025_bib11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/bjc.2016.172","article-title":"CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer","volume":"115","author":"Bronger","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cell.2017.07.025_bib12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1101\/gr.165985.113","article-title":"Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival","volume":"24","author":"Brown","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.cell.2017.07.025_bib13","doi-asserted-by":"crossref","first-page":"e1003266","DOI":"10.1371\/journal.pcbi.1003266","article-title":"Properties of MHC class I presented peptides that enhance immunogenicity","volume":"9","author":"Calis","year":"2013","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.cell.2017.07.025_bib14","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2017.07.025_bib15","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1158\/1078-0432.CCR-1016-03","article-title":"Cellular immunity in breast cancer patients completing taxane treatment","volume":"10","author":"Carson","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2017.07.025_bib16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nbt.2203","article-title":"Absolute quantification of somatic DNA alterations in human cancer","volume":"30","author":"Carter","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cell.2017.07.025_bib17","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccr.2011.11.006","article-title":"Combined genetic inactivation of \u03b22-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma","volume":"20","author":"Challa-Malladi","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2017.07.025_bib18","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1158\/2159-8290.CD-15-1545","article-title":"Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade","volume":"6","author":"Chen","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cell.2017.07.025_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nbt.2514","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples","volume":"31","author":"Cibulskis","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cell.2017.07.025_bib20","doi-asserted-by":"crossref","first-page":"eaaf8399","DOI":"10.1126\/science.aaf8399","article-title":"Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy","volume":"355","author":"Davoli","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.cell.2017.07.025_bib21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.molonc.2013.10.006","article-title":"Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: the role of massively parallel sequencing","volume":"8","author":"De Mattos-Arruda","year":"2014","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.cell.2017.07.025_bib22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nature10803","article-title":"Expression of tumour-specific antigens underlies cancer immunoediting","volume":"482","author":"DuPage","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cell.2017.07.025_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.cell.2017.07.025_bib24","doi-asserted-by":"crossref","first-page":"D481","DOI":"10.1093\/nar\/gkv1351","article-title":"The reactome pathway knowledgebase","volume":"44","author":"Fabregat","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cell.2017.07.025_bib25","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1186\/gb-2011-12-1-r1","article-title":"A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries","volume":"12","author":"Fisher","year":"2011","journal-title":"Genome Biol."},{"key":"10.1016\/j.cell.2017.07.025_bib26","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ccell.2015.10.012","article-title":"Immunological effects of conventional chemotherapy and targeted anticancer agents","volume":"28","author":"Galluzzi","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2017.07.025_bib27","doi-asserted-by":"crossref","first-page":"791603","DOI":"10.1155\/2010\/791603","article-title":"Immune response in ovarian cancer: how is the immune system involved in prognosis and therapy: potential for treatment utilization","volume":"2010","author":"Gavalas","year":"2010","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.cell.2017.07.025_bib28","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2017.07.025_bib29","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.celrep.2016.03.075","article-title":"Genomic correlates of immune-cell infiltrates in colorectal carcinoma","volume":"15","author":"Giannakis","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2017.07.025_bib30","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nbt.1523","article-title":"Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing","volume":"27","author":"Gnirke","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cell.2017.07.025_bib31","doi-asserted-by":"crossref","first-page":"6879","DOI":"10.1073\/pnas.96.12.6879","article-title":"Broad tumor-associated expression and recognition by tumor-derived gamma delta T\u00a0cells of MICA and MICB","volume":"96","author":"Groh","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2017.07.025_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.cell.2017.07.025_bib33","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1200\/JCO.2015.63.7785","article-title":"Targeting programmed cell death 1 in ovarian cancer","volume":"33","author":"Homicsko","year":"2016","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.cell.2017.07.025_bib34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cell.2017.07.025_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.cell.2017.07.025_bib36","doi-asserted-by":"crossref","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","article-title":"KEGG as a reference resource for gene and protein annotation","volume":"44","author":"Kanehisa","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cell.2017.07.025_bib37","doi-asserted-by":"crossref","first-page":"W525","DOI":"10.1093\/nar\/gks438","article-title":"Immune epitope database analysis resource","volume":"40","author":"Kim","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cell.2017.07.025_bib38","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1128\/JVI.02632-06","article-title":"The CD8+ T-cell response to lymphocytic choriomeningitis virus involves the L antigen: uncovering new tricks for an old virus","volume":"81","author":"Kotturi","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2017.07.025_bib39","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature14426","article-title":"Mutant MHC class II epitopes drive therapeutic immune responses to cancer","volume":"520","author":"Kreiter","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cell.2017.07.025_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13059-015-0617-1","article-title":"CopywriteR: DNA copy number detection from off-target sequence data","volume":"16","author":"Kuilman","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.cell.2017.07.025_bib41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12885-015-1077-4","article-title":"Tumor evolution and intratumor heterogeneity of an epithelial ovarian cancer investigated using next-generation sequencing","volume":"15","author":"Lee","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cell.2017.07.025_bib42","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/biof.1155","article-title":"Rho GTPases and cancer","volume":"40","author":"Li","year":"2014","journal-title":"Biofactors"},{"key":"10.1016\/j.cell.2017.07.025_bib43","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1084\/jem.182.5.1301","article-title":"Human Mig chemokine: biochemical and functional characterization","volume":"182","author":"Liao","year":"1995","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cell.2017.07.025_bib44","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"Liberzon","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cell.2017.07.025_bib45","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/bioinformatics\/btn128","article-title":"Accurate approximation method for prediction of class I MHC affinities for peptides of length 8, 10 and 11 using prediction tools trained on 9mers","volume":"24","author":"Lundegaard","year":"2008","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cell.2017.07.025_bib46","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature10755","article-title":"Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting","volume":"482","author":"Matsushita","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cell.2017.07.025_bib47","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Immune checkpoint blockade","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cell.2017.07.025_bib48","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1158\/2159-8290.CD-13-0985","article-title":"T-cell and NK-cell infiltration into solid tumors: a key limiting factor for efficacious cancer immunotherapy","volume":"4","author":"Melero","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cell.2017.07.025_bib49","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.coi.2016.05.010","article-title":"Genomic determinants of cancer immunotherapy","volume":"41","author":"Miao","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cell.2017.07.025_bib50","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nbt1215","article-title":"A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus","volume":"24","author":"Moutaftsi","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cell.2017.07.025_bib51","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1158\/2159-8290.CD-15-0412","article-title":"Tracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapy","volume":"5","author":"Murugaesu","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cell.2017.07.025_bib52","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1126\/science.8342042","article-title":"Selective and ATP dependent translocation of peptides by the MHC encoded transporter","volume":"261","author":"Neefjes","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.cell.2017.07.025_bib53","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cell.2017.07.025_bib54","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/1471-2105-10-296","article-title":"NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction","volume":"10","author":"Nielsen","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.cell.2017.07.025_bib55","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1110\/ps.0239403","article-title":"Reliable prediction of T-cell epitopes using neural networks with novel sequence representations","volume":"12","author":"Nielsen","year":"2003","journal-title":"Protein Sci."},{"key":"10.1016\/j.cell.2017.07.025_bib56","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1096-0031.1999.tb00277.x","article-title":"The parsimony ratchet, a new method for rapid parsimony analysis","volume":"15","author":"Nixon","year":"1999","journal-title":"Cladistics"},{"key":"10.1016\/j.cell.2017.07.025_bib57","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nature14410","article-title":"Whole-genome characterization of chemoresistant ovarian cancer","volume":"521","author":"Patch","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cell.2017.07.025_bib58","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.4049\/jimmunol.1302101","article-title":"HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity","volume":"191","author":"Paul","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.cell.2017.07.025_bib59","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1471-2105-6-132","article-title":"Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method","volume":"6","author":"Peters","year":"2005","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.cell.2017.07.025_bib60","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.immuni.2015.11.024","article-title":"Immunogenic chemotherapy sensitizes tumors to checkpoint blockade therapy","volume":"44","author":"Pfirschke","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2017.07.025_bib61","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/354528a0","article-title":"Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter","volume":"354","author":"Powis","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.cell.2017.07.025_bib62","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1530\/REP-12-0153","article-title":"The emerging role of CXC chemokines in epithelial ovarian cancer","volume":"144","author":"Rainczuk","year":"2012","journal-title":"Reproduction"},{"key":"10.1016\/j.cell.2017.07.025_bib63","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1158\/1078-0432.CCR-12-3847","article-title":"Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin","volume":"19","author":"Remark","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2017.07.025_bib64","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41525-017-0013-8","article-title":"Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma","volume":"2","author":"Reuben","year":"2017","journal-title":"Npj Genomic Med."},{"key":"10.1016\/j.cell.2017.07.025_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/science.aaa1348","article-title":"Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cell.2017.07.025_bib66","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cell.2017.07.025_bib67","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.cell.2017.07.025_bib68","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nmeth.2883","article-title":"PyClone: statistical inference of clonal population structure in cancer","volume":"11","author":"Roth","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cell.2017.07.025_bib69","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1148\/radiol.11110175","article-title":"Advanced ovarian cancer: multiparametric MR imaging demonstrates response- and metastasis-specific effects","volume":"263","author":"Sala","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.cell.2017.07.025_bib70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4137\/GRSB.S11433","article-title":"A comprehensive profile of ChIP-Seq-based STAT1 target genes suggests the complexity of STAT1-mediated gene regulatory mechanisms","volume":"7","author":"Satoh","year":"2013","journal-title":"Gene Regul. Syst. Bio."},{"key":"10.1016\/j.cell.2017.07.025_bib71","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/bioinformatics\/btq706","article-title":"phangorn: phylogenetic analysis in R","volume":"27","author":"Schliep","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cell.2017.07.025_bib72","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s13059-016-1092-z","article-title":"Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures","volume":"17","author":"\u015eenbabao\u011flu","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.cell.2017.07.025_bib73","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cell.2017.07.025_bib74","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/nbt.3344","article-title":"Comprehensive analysis of cancer-associated somatic mutations in class\u00a0I\u00a0HLA genes","volume":"33","author":"Shukla","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cell.2017.07.025_bib75","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1745-7580-4-2","article-title":"Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries","volume":"4","author":"Sidney","year":"2008","journal-title":"Immunome Res."},{"key":"10.1016\/j.cell.2017.07.025_bib76","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cell.2017.07.025_bib77","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity","volume":"523","author":"Spranger","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cell.2017.07.025_bib78","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","article-title":"Tumor-residing Batf3 dendritic cells are required for effector T\u00a0cell trafficking and adoptive T\u00a0cell therapy","volume":"31","author":"Spranger","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2017.07.025_bib79","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1158\/2326-6066.CIR-16-0031","article-title":"Immune profiling of adenoid cystic carcinoma: PD-L2 expression and associations with tumor-infiltrating lymphocytes","volume":"4","author":"Sridharan","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.cell.2017.07.025_bib80","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/9858","article-title":"Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices","volume":"17","author":"Sturniolo","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cell.2017.07.025_bib81","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JCO.2011.38.3224","article-title":"Pretreatment epidermal growth factor receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer","volume":"30","author":"Su","year":"2012","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.cell.2017.07.025_bib82","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2017.07.025_bib83","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1126\/science.8191286","article-title":"Interaction of MHC class I molecules with the transporter associated with antigen processing","volume":"264","author":"Suh","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.cell.2017.07.025_bib84","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.1158\/1078-0432.CCR-05-0883","article-title":"Gemcitabine selectively eliminates splenic Gr-1+\/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity","volume":"11","author":"Suzuki","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2017.07.025_bib85","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1093\/bioinformatics\/btu548","article-title":"OptiType: precision HLA typing from next-generation sequencing data","volume":"30","author":"Szolek","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cell.2017.07.025_bib86","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.cell.2017.07.025_bib87","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1172\/JCI80004","article-title":"From mice to humans: developments in cancer immunoediting","volume":"125","author":"Teng","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.cell.2017.07.025_bib88","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/bib\/bbs017","article-title":"Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration","volume":"14","author":"Thorvaldsd\u00f3ttir","year":"2013","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.cell.2017.07.025_bib89","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1609279","article-title":"T-cell transfer therapy targeting mutant KRAS in cancer","volume":"375","author":"Tran","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2017.07.025_bib90","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2009.11.022","article-title":"Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC","volume":"17","author":"Turke","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2017.07.025_bib91","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature18945","article-title":"Neoantigen landscape dynamics during human melanoma-T cell interactions","volume":"536","author":"Verdegaal","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cell.2017.07.025_bib92","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"Vetizou","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cell.2017.07.025_bib93","doi-asserted-by":"crossref","first-page":"D405","DOI":"10.1093\/nar\/gku938","article-title":"The immune epitope database (IEDB) 3.0","volume":"43","author":"Vita","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cell.2017.07.025_bib94","doi-asserted-by":"crossref","first-page":"e1000048","DOI":"10.1371\/journal.pcbi.1000048","article-title":"A\u00a0systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach","volume":"4","author":"Wang","year":"2008","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.cell.2017.07.025_bib95","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/1471-2105-11-568","article-title":"Peptide binding predictions for HLA DR, DP and DQ molecules","volume":"11","author":"Wang","year":"2010","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.cell.2017.07.025_bib96","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.cell.2016.04.009","article-title":"Effector T\u00a0cells abrogate stroma-mediated chemoresistance in ovarian cancer","volume":"165","author":"Wang","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cell.2017.07.025_bib97","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2017.07.025_bib98","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations associated with acquired resistance to PD-1 blockade in melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2017.07.025_bib99","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T\u00a0cells, recurrence, and survival in epithelial ovarian cancer","volume":"348","author":"Zhang","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2017.07.025_bib100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nri2216","article-title":"Immunological aspects of cancer chemotherapy","volume":"8","author":"Zitvogel","year":"2008","journal-title":"Nat. Rev. Immunol."}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867417308322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867417308322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T05:03:09Z","timestamp":1535432589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867417308322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":100,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0092867417308322"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2017.07.025","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2017.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}